Joseph Reoux, MD

Faculty Appointment(s)

Associate Professor

jreoux@uw.edu

206-277-1747

Personal Statement

My primary interest and expertise is in the assessment and treatment of substance use disorders in adults, including those with co-occurring psychiatric disorders and individuals needing stabilization early in their episode of care.   Assisting treatment with medication to manage withdrawal symptoms or support ongoing abstinence are also areas of expertise, combined with a psychotherapeutic approach incorporating motivation enhancement, twelve-step facilitation, cognitive-behavioral, supportive, and psychodynamic perspectives to promote recovery.  I am also involved in the clinical and didactic education of medical students, nurse practitioner students, medicine residents, psychiatry residents and addiction fellows.

Department Affiliations

Training Programs

Recent Publications

Naltrexone augmented with prazosin for alcohol use disorder: results from a randomized controlled proof-of-concept trial.
(2024 Jul 21)
Alcohol Alcohol 59(5):
Simpson TL, Achtmeyer C, Batten L, Reoux J, Shofer J, Peskind ER, Saxon AJ, Raskind MA
Outpatient treatment engagement and abstinence rates following inpatient opioid detoxification.
(2006)
J Addict Dis 25(4): 27-35
Davison JW, Sweeney ML, Bush KR, Davis Correale TM, Calsyn DA, Reoux JP, Sloan KL, Kivlahan DR
A comparison of two versions of the clinical institute withdrawal assessment for alcohol: the CIWA-Ar and CIWA-AD.
(2006 Jan-Feb)
Am J Addict 15(1): 85-93
Reoux JP, Oreskovich MR
Pharmacokinetic profile of an oral loading dose of divalproex sodium during acute alcohol withdrawal.
(2006 Feb)
J Clin Psychopharmacol 26(1): 105-7
Reoux JP, Saxon AJ, Shen D
A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin.
(2005 Jan 7)
Drug Alcohol Depend 77(1): 71-9
Oreskovich MR, Saxon AJ, Ellis ML, Malte CA, Reoux JP, Knox PC
Show complete publication list »
Edit Profile